Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.

Devereux, Richard B

Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. [electronic resource] - Circulation Sep 2004 - 1456-62 p. digital

Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

1524-4539

10.1161/01.CIR.0000141573.44737.5A doi


Adrenergic beta-Antagonists--therapeutic use
Aged
Aged, 80 and over
Angiotensin II Type 1 Receptor Blockers--therapeutic use
Antihypertensive Agents--therapeutic use
Atenolol--therapeutic use
Blood Pressure--drug effects
Double-Blind Method
Female
Follow-Up Studies
Heart Rate--drug effects
Heart Ventricles--diagnostic imaging
Humans
Hypertension--complications
Hypertrophy, Left Ventricular--diagnostic imaging
Losartan--therapeutic use
Male
Middle Aged
Organ Size
Prospective Studies
Treatment Outcome
Ultrasonography